Partial response or better at six months is prognostic of superior progression-free survival in Waldenström macroglobulinaemia patients treated with ibrutinib
| Image |  |
|---|---|
| Description | scientific article published on 18 November 2020 |
| Author/s | |
| Publication date | November 18, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |